Application of artificial intelligence to hepatobiliary cancer clinical outcomes research

Abstract

The rapid evolution of modern technology has made artificial intelligence (AI) an important emerging tool in healthcare. AI, which is a broad field of computer science, can be used to develop systems or machines equipped with the ability to tackle tasks that traditionally necessitate human intelligence. AI can be used to perform multifaceted tasks that involve the synthesis of large amounts of data with the generation of solutions, algorithms, and decision support tools. Various AI approaches, including machine learning (ML) and natural language processing (NLP), are increasingly being used to analyze vast healthcare datasets. In addition, visual AI has the potential to revolutionize surgery and the intraoperative experience for surgeons through augmented reality enhancing surgical navigation in real-time. Specific applications of AI in hepatobiliary tumors such as hepatocellular carcinoma and biliary tract cancer can improve patient diagnosis, prognostic risk stratification, as well as treatment allocation based on ML-based models. The integration of radiomics data and AI models can also improve clinical decision making. We herein review how AI may be of particular interest in the care of patients with complex cancers, such as hepatobiliary tumors, as these patients often require a multimodal treatment approach.

Keywords

Artificial intelligence / hepatocellular carcinoma, cholangiocarcinoma, outcome research

References

[1] McCarthy J. What is artificial intelligence? 2004. Available from: https://cse.unl.edu/~choueiry/S09-476-876/Documents/whatisai.pdf. [Last accessed on 24 May 2024]

[2] Yu KH,Kohane IS.Artificial intelligence in healthcare.Nat Biomed Eng2018;2:719-31

[3] Jha S.Adapting to artificial intelligence: radiologists and pathologists as information specialists.JAMA2016;316:2353-4

[4] Placona AM,McGehee H,Klassen DK.Can donor narratives yield insights? A natural language processing proof of concept to facilitate kidney allocation.Am J Transplant2020;20:1095-104

[5] Kelly CJ,Suleyman M,King D.Key challenges for delivering clinical impact with artificial intelligence.BMC Med2019;17:195 PMCID:PMC6821018

[6] Hua KL,Hidayati SC,Chen YJ.Computer-aided classification of lung nodules on computed tomography images via deep learning technique.Onco Targets Ther2015;8:2015-22 PMCID:PMC4531007

[7] Jiang Z,Trieu PDY.Evaluating recalibrating AI models for breast cancer diagnosis in a new context: insights from transfer learning, image enhancement and high-quality training data integration.Cancers2024;16:322 PMCID:PMC10814142

[8] Escobar GJ,Ragins A.Piloting electronic medical record-based early detection of inpatient deterioration in community hospitals.J Hosp Med2016;11:S18-24 PMCID:PMC5510649

[9] Rajkomar A,Chen K.Scalable and accurate deep learning with electronic health records.NPJ Digit Med2018;1:18 PMCID:PMC6550175

[10] Xu J,Xue S.Translating cancer genomics into precision medicine with artificial intelligence: applications, challenges and future perspectives.Hum Genet2019;138:109-24 PMCID:PMC6373233

[11] Foster JC,Ruberg SJ.Subgroup identification from randomized clinical trial data.Stat Med2011;30:2867-80 PMCID:PMC3880775

[12] Interpretable AI. Optimal decision trees. Available from: https://www.interpretable.ai/products/optimal-trees/. [Last accessed on 24 May 2024]

[13] Endo Y,Moazzam Z.Postoperative morbidity after simultaneous versus staged resection of synchronous colorectal liver metastases: impact of hepatic tumor burden.Surgery2024;175:432-40

[14] Endo Y,Moazzam Z.Optimal policy tree to assist in adjuvant therapy decision-making after resection of colorectal liver metastases.Surgery2024;175:645-53

[15] Paul D,Shenoy S,Kalia K.Artificial intelligence in drug discovery and development.Drug Discov Today2021;26:80-93 PMCID:PMC7577280

[16] Sageshima J,Goussous N,Perez R.Prediction of high-risk donors for kidney discard and nonrecovery using structured donor characteristics and unstructured donor narratives.JAMA Surg2024;159:60-8 PMCID:PMC10620675

[17] Wahl B,Germann S.Artificial intelligence (AI) and global health: how can AI contribute to health in resource-poor settings?.BMJ Glob Health2018;3:e000798 PMCID:PMC6135465

[18] Mollica V,Marchetti A.The impact of ECOG performance status on efficacy of immunotherapy and immune-based combinations in cancer patients: the MOUSEION-06 study.Clin Exp Med2023;23:5039-49

[19] Gong X,Zhao L.Big data toolsets to pharmacometrics: application of machine learning for time-to-event analysis.Clin Transl Sci2018;11:305-11 PMCID:PMC5944589

[20] Barber EL,Persenaire C.Natural language processing with machine learning to predict outcomes after ovarian cancer surgery.Gynecol Oncol2021;160:182-6 PMCID:PMC7779704

[21] Resende V,Endo Y.Machine-based learning hierarchical cluster analysis: sex-based differences in prognosis following resection of hepatocellular carcinoma.World J Surg2023;47:3319-27

[22] Boulesteix AL,Kruppa J.Overview of random forest methodology and practical guidance with emphasis on computational biology and bioinformatics.WIREs Data Mining Knowl Discov2012;2:493-507

[23] Friedman JH.Greedy function approximation: a gradient boosting machine.Ann Statist2001;29:1189-232

[24] Lai Q,Mennini G.Prognostic role of artificial intelligence among patients with hepatocellular cancer: a systematic review.World J Gastroenterol2020;26:6679-88 PMCID:PMC7673961

[25] Cover T.Nearest neighbor pattern classification.IEEE Trans Inform Theory1967;13:21-7

[26] Patel H,Hewitt DB.Deep learning applications in pancreatic cancer.Cancers2024;16:436 PMCID:PMC10814475

[27] Wakabayashi T,Gonzalez-Cabrera C.Radiomics in hepatocellular carcinoma: a quantitative review.Hepatol Int2019;13:546-59 PMCID:PMC7613479

[28] Endo Y,Moazzam Z.Quality of ChatGPT responses to questions related to liver transplantation.J Gastrointest Surg2023;27:1716-9

[29] Rajkomar A,Chen K.Automatically charting symptoms from patient-physician conversations using machine learning.JAMA Intern Med2019;179:836-8 PMCID:PMC6547250

[30] Moazzam Z,Endo Y,Needleman B.A Paradigm shift: online artificial intelligence platforms as an informational resource in bariatric surgery.Obes Surg2023;33:2611-4

[31] Ali SR,Tarafdar A.Natural language processing to automate a web-based model of care and modernize skin cancer multidisciplinary team meetings.Br J Surg2024;111:znad347 PMCID:PMC10782209

[32] Bcharah G,Panico N.Innovations in spine surgery: a narrative review of current integrative technologies.World Neurosurg2024;184:127-36

[33] Choksi S,Zang C.Bringing Artificial Intelligence to the operating room: edge computing for real-time surgical phase recognition.Surg Endosc2023;37:8778-84

[34] Takeuchi M,Saito K.Automated surgical-phase recognition for robot-assisted minimally invasive esophagectomy using artificial intelligence.Ann Surg Oncol2022;29:6847-55

[35] Reig M,Rimola J.BCLC strategy for prognosis prediction and treatment recommendation: the 2022 update.J Hepatol2022;76:681-93 PMCID:PMC8866082

[36] Matsumoto M,Shiba H.Treatment of intrahepatic recurrence after hepatectomy for hepatocellular carcinoma.Ann Gastroenterol Surg2021;5:538-52 PMCID:PMC8316745

[37] Famularo S, Donadon M, Cipriani F, et al; HE.RC.O.LE.S. Group. Machine learning predictive model to guide treatment allocation for recurrent hepatocellular carcinoma after surgery.JAMA Surg2023;158:192-202 PMCID:PMC9857766

[38] Moazzam Z,Endo Y.A prognostic model to predict survival after recurrence among patients with recurrent hepatocellular carcinoma.Ann Surg2024;279:471-8

[39] Tibshirani R.Regression shrinkage and selection via the lasso.J R Stat Soc Ser B Stat Method1996;58:267-88

[40] Wang K,Yan J.A deep learning model with incorporation of microvascular invasion area as a factor in predicting prognosis of hepatocellular carcinoma after R0 hepatectomy.Hepatol Int2022;16:1188-98

[41] Ji GW,Sun DW.Machine learning to improve prognosis prediction of early hepatocellular carcinoma after surgical resection.J Hepatocell Carcinoma2021;8:913-23 PMCID:PMC8370036

[42] Iseke S,Kucukkaya AS.Machine learning models for prediction of posttreatment recurrence in early-stage hepatocellular carcinoma using pretreatment clinical and MRI features: a proof-of-concept study.AJR Am J Roentgenol2023;220:245-55 PMCID:PMC10015590

[43] Saillard C,Laifa O.Predicting survival after hepatocellular carcinoma resection using deep learning on histological slides.Hepatology2020;72:2000-13

[44] Endo Y,Lima HA.A novel online calculator to predict risk of microvascular invasion in the preoperative setting for hepatocellular carcinoma patients undergoing curative-intent surgery.Ann Surg Oncol2023;30:725-33

[45] Yao S,Wei Y,Song B.Radiomics in hepatocellular carcinoma: a state-of-the-art review.World J Gastrointest Oncol2021;13:1599-615 PMCID:PMC8603458

[46] Lewis S,Taouli B.Radiomics of hepatocellular carcinoma.Abdom Radiol2021;46:111-23

[47] Ma X,Gu D.Preoperative radiomics nomogram for microvascular invasion prediction in hepatocellular carcinoma using contrast-enhanced CT.Eur Radiol2019;29:3595-605

[48] Zhu YJ,Wang S.Model-based three-dimensional texture analysis of contrast-enhanced magnetic resonance imaging as a potential tool for preoperative prediction of microvascular invasion in hepatocellular carcinoma.Oncol Lett2019;18:720-32 PMCID:PMC6546996

[49] Jiang YQ,Cao S.Preoperative identification of microvascular invasion in hepatocellular carcinoma by XGBoost and deep learning.J Cancer Res Clin Oncol2021;147:821-33 PMCID:PMC7873117

[50] American Cancer Society. Key statistics for bile duct cancer. Available from: https://www.cancer.org/cancer/types//bile-duct-cancer/about/key-statistics.html. [Last accessed on 24 May 2024]

[51] Alaimo L,Moazzam Z.Development and validation of a machine-learning model to predict early recurrence of intrahepatic cholangiocarcinoma.Ann Surg Oncol2023;30:5406-15

[52] Sasaki K,Conci S.The tumor burden score: a new “metro-ticket” prognostic tool for colorectal liver metastases based on tumor size and number of tumors.Ann Surg2018;267:132-41

[53] Cotter G,Poultsides GA.Using machine learning to preoperatively stratify prognosis among patients with gallbladder cancer: a multi-institutional analysis.HPB2022;24:1980-8

[54] Tsilimigras DI,Paredes AZ.A novel classification of intrahepatic cholangiocarcinoma phenotypes using machine learning techniques: an international multi-institutional analysis.Ann Surg Oncol2020;27:5224-32

[55] Chen B,Li J.Predicting very early recurrence in intrahepatic cholangiocarcinoma after curative hepatectomy using machine learning radiomics based on CECT: a multi-institutional study.Comput Biol Med2023;167:107612

[56] Endo Y,Lima HA.The impact of tumor location on the value of lymphadenectomy for intrahepatic cholangiocarcinoma.HPB2023;25:650-8

[57] Mueller M,Mizuno T.Perihilar cholangiocarcinoma - novel benchmark values for surgical and oncological outcomes from 24 expert centers.Ann Surg2021;274:780-8

[58] van Keulen AM, Buettner S, Erdmann JI, et al; perihilar cholangiocarcinoma collaboration group. Multivariable prediction model for both 90-day mortality and long-term survival for individual patients with perihilar cholangiocarcinoma: does the predicted survival justify the surgical risk?.Br J Surg2023;110:599-605 PMCID:PMC10364519

[59] Ratti F, Marino R, Olthof PB, et al; Perihilar Cholangiocarcinoma Collaboration Group. Predicting futility of upfront surgery in perihilar cholangiocarcinoma: Machine learning analytics model to optimize treatment allocation.Hepatology2024;79:341-54

[60] Alaimo L,Endo Y.The application of artificial intelligence to investigate long-term outcomes and assess optimal margin width in hepatectomy for intrahepatic cholangiocarcinoma.Ann Surg Oncol2023;30:4292-301

[61] Laplante S,Kiani P.Validation of an artificial intelligence platform for the guidance of safe laparoscopic cholecystectomy.Surg Endosc2023;37:2260-8

[62] Madani A,Altieri MS.Artificial intelligence for intraoperative guidance: using semantic segmentation to identify surgical anatomy during laparoscopic cholecystectomy.Ann Surg2022;276:363-9 PMCID:PMC8186165

[63] Alaimo L,Lima HA.A comprehensive preoperative predictive score for post-hepatectomy liver failure after hepatocellular carcinoma resection based on patient comorbidities, tumor burden, and liver function: the CTF score.J Gastrointest Surg2022;26:2486-95

[64] Winkel DJ,Breit HC.Validation of a fully automated liver segmentation algorithm using multi-scale deep reinforcement learning and comparison versus manual segmentation.Eur J Radiol2020;126:108918

[65] Ruzzenente A,D’Onofrio M.Perihilar cholangiocarcinoma: three-dimensional modelling algorithm to estimate tumour extension and bile duct resection margins.Br J Surg2024;111:znad428

[66] Tomiyama K,Hernandez-Alejandro R.Looking beyond the horizon: patient-specific rehearsals for complex liver surgeries with 3D printed model.Ann Surg2021;273:e28-30

[67] Ntourakis D,Soler L,Mutter D.Augmented reality guidance for the resection of missing colorectal liver metastases: an initial experience.World J Surg2016;40:419-26

[68] Pessaux P,Soler L,Mutter D.Towards cybernetic surgery: robotic and augmented reality-assisted liver segmentectomy.Langenbecks Arch Surg2015;400:381-5

[69] Ossa L, Lorenzini G, Milford SR, Shaw D, Elger BS, Rost M. Integrating ethics in AI development: a qualitative study.BMC Med Ethics2024;25:10 PMCID:PMC10804710